Clinical Trials Sponsored by D-Rev

Total 2082 results

D-Pharm Ltd.

Withdrawn

DP-VPA for Migraine Prophylaxis, a Pilot Efficacy Study

Migraine

Israel
R&D Cardiologie

Completed

Thrombectomy and Improvement of Left Ventricular Function in AMI

Acute Myocardial Infarction | Ventricular Remodeling

Netherlands
University of California, Merced
Ministry of Health, Rwanda; Rwanda Pediatric Association; Rwanda Bio-Medical... and other collaborators

Completed

Understanding Neonatal Jaundice in Rwanda

Jaundice, Neonatal

Rwanda
PepsiCo Global R&D

Completed

Utility of Transdermal Optical Imaging (TOI) as a Non-invasive Measure of Hydration Status: Phase 3a for Model Development

Dehydration

United States
PepsiCo Global R&D

Completed

Influence of Coffeeberry Ingestion on Soccer Skill Performance

Skill Performance | Soccer Performance | Coffeeberry Effects

United Kingdom
PepsiCo Global R&D

Completed

Pilot Study Characterizing the Pharmacokinetic Profile of a Novel Encapsulated Caffeine Beverage in the Fed and Fasted States

Pharmacokinetics

United States
PepsiCo Global R&D

Completed

Liking Adaptation to Beverages of Varying Sweetness Levels Following Prolonged Exposure

Sweetness Liking Adaptation

Mexico
PepsiCo Global R&D

Completed

Sleep, Physical Activity, and Dietary Habits Among High School Student-athletes and Non-athletes During an Academic Semester

Sleep Quantity | Sleep Efficiency

United States
PepsiCo Global R&D

Completed

Avenanthramides and Exercise

Avenanthramides
PepsiCo Global R&D

Completed

Effect of Phytochemicals on Aspects of Cognitive Performance

Cognitive Performance

United States
PepsiCo Global R&D

Completed

Assess Extent of Agreement Between Online 24-hr Dietary Recall and Interviewer-administered 24-hr Dietary Recall on the Same Day for 2 Non-consecutive 2 Days 1 wk Apart to Adults and School Age Children

Dietary Habits

Russian Federation
Servei Central d' Anestesiologia

Completed

Opioid-Free Anesthesia for Patients With Joint Hypermobility Syndrome Undergoing Craneo-Cervical Fixation: A Case-series

Ehlers-Danlos Syndrome | Craniocervical Syndrome

Spain
PepsiCo Global R&D

Completed

Effects of Hydrolyzed Collagen and Vitamin C on Explosive Performance

Collagen Synthesis | Rate of Force (RFD) Development

United States
PepsiCo Global R&D

Completed

Effects of Beverages Containing Orange or Apple Pomace on Digestive Health in Adults

Digestive Health

United States
PepsiCo Global R&D

Completed

The Effect of Oats Containing 1.4g Beta Glucan on Fecal Bacterial Population(s) and Plasma Cholesterol in Healthy Adults With Elevated Cholesterol Levels

Microbiome | Plasma Cholesterol | Prebiotic

Ireland
PepsiCo Global R&D

Completed

Supplementary Food on Prevention of Moderate Malnutrition in Children

Moderate Acute Malnutrition (MAM)

Mexico
PepsiCo Global R&D

Completed

The Effect on Glycemic Responses and Subjective Ratings of Satiety of a Snack With or Without Ingredients to Slow Carbohydrate Digestion

Glycemic Response; Satiety
PepsiCo Global R&D

Completed

The Impact of Supplementation With Novel Prototype Nutrition Bar on Nitric Oxide Bioavailability and Measures of Athlete Performance

Exercise Performance

United Kingdom
PepsiCo Global R&D

Completed

Glycemic and Insulinemic Impact of a Test Granola Versus a Control Granola

Glycemic | Insulinemic | Subjective Hunger Responses

Canada
PepsiCo Global R&D

Completed

Glycemic and Insulinemic Impact of a Test Granola 2 Versus a Control Granola

Glycemic Response | Insulinemic Response | Subject Hunger Response

Canada
PepsiCo Global R&D

Completed

Glycemic and Insulinemic Impact of Oats With Additional Dried Fruits, Nuts and Seeds Soaked Overnight

Blood Glucose; Subjective Hunger, Insulin

Canada
PepsiCo Global R&D

Completed

Glycemic and Insulinemic Response to Oats Soaked Overnight in Milk Compared to Cream of Rice in Healthy Subjects

Glycemic, Insulinemic, Subjective Appetite Responses

Canada
Janssen R&D Ireland

Completed

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection

Chronic Hepatitis C | Genotype 4 Chronic Hepatitis C

Spain
Vernalis (R&D) Ltd

Completed

Study of the Safety, Tolerability and Efficacy of V3381 in Patients With Diabetic Peripheral Neuropathic Pain

Diabetic Peripheral Neuropathic Pain

United States, United Kingdom, Canada, Czech Republic
Janssen R&D Ireland

Completed

TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy (ATTAIN)

Hepatitis C

United States, Australia, France, Poland, United Kingdom, Germany, Spain, Belgium, Israel, Portugal, Bulgaria, Romania, Denmark, Greece, Sweden, Canada, Czech Republic, Argentina, Brazil, Austria, Hungary, Switzerland, Puerto Rico, No...
Janssen R&D Ireland

Completed

A Study to Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C Virus

Chronic Hepatitis C

Belgium, Germany
Janssen R&D Ireland

Completed

An Efficacy, Pharmacokinetics, Safety and Tolerability Study of TMC435 as Part of a Treatment Regimen for Hepatitis C-Infected Patients

Hepatitis C, Chronic

China, Korea, Republic of
PepsiCo Global R&D

Completed

Effect of Oats on Lipid Profile

Mildly Hypercholesterolemic Subjects
Janssen R&D Ireland

Completed

A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1

Hepatitis C Virus Genotype-1

United States, France, United Kingdom, Germany, Spain, Portugal, Canada, Puerto Rico
PepsiCo Global R&D

Unknown

Plant Based Extracts and Cognition (CEOPTB)

Change in Cognitive Function and Fatigue During Extended Performance of the Cognitive Demand Battery (CDB) at 1, 3 and 6 Hours Post Consumption | Change in Long Term Declarative Memory at 1, 3 and 6 Hours Post-intervention.

United Kingdom
Janssen R&D Ireland

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.

Healthy

United States
Janssen R&D Ireland

Completed

An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Participants (QUEST-2)

Hepatitis C

United States, France, Poland, Belgium, Germany, Spain, Portugal, Bulgaria, Turkey, Argentina, Brazil, Austria, Netherlands, Slovakia, Puerto Rico
Newtricious R&D BV

Completed

Effect of NWT-03 on Blood Pressure

Blood Pressure | Albuminuria

Ireland
Janssen R&D Ireland

Terminated

Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382

Chronic Hepatitis C Infection

Germany
Janssen R&D Ireland

Completed

A Study to Explore the Pharmacokinetics of Rilpivirine With Rifabutin in Healthy Participants

Healthy

Belgium
Janssen R&D Ireland

Completed

Study to Examine Multiple Doses of TMC647055 in Combination With Telaprevir

Hepatitis C

Germany
Janssen R&D Ireland

Completed

TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients

HIV Infections | Acquired Immunodeficiency Syndrome

United States, France, Argentina, South Africa, Thailand
Janssen R&D Ireland

Completed

A Study to Compare the Bioavailability of JNJ-47910382 Formulated as a Tablet and as Suspension in Healthy Participants

Healthy Participants

Belgium
Janssen R&D Ireland

Completed

A Study to Assess Bioavailability & Food Effect of Different Liquid and Capsule Formulations of TMC435.

Healthy Volunteers

United Kingdom
Janssen R&D Ireland

Completed

A Study to Assess the Bioequivalence of Darunavir When Co-Administrated With Cobicistat Under Fed and Fasted Conditions

Healthy Participants

Belgium
Janssen R&D Ireland

Completed

A Study in Healthy Participants Investigating the Safety, Tolerability and Plasma Pharmacokinetics (PK) of Single Oral Doses of JNJ-47910382

Hepatitis C Virus Infection

Germany
Vernalis (R&D) Ltd

Completed

Single and Multiple Ascending Dose Study of V158866 in Healthy Volunteers

First in Man Study

United Kingdom
Vernalis (R&D) Ltd

Completed

A Clinical Trial to Find Out V81444's Side Effects and Blood Levels in Healthy Men

Parkinson's Disease

United Kingdom
CM&D Pharma Limited

Completed

Estrogen Receptor Beta Agonists (Eviendep) and Polyp Recurrence (CRC)

Adenocarcinoma of Colon Recurrent

Italy
Vernalis (R&D) Ltd

Completed

Safety and Efficacy of Low Doses of V24343 in Obese Subjects

Obesity

United Kingdom
PepsiCo Global R&D

Recruiting

Transdermal Optical Imaging (TOI) as a Non-invasive Measure to Detect Changes in Hydration Status in Healthy Adults and Athletes

Dehydration

United States
PepsiCo Global R&D

Recruiting

Aspire2B Personalization Pilot Study Program

Behavior | Lifestyle | App Proficiency

United States
PepsiCo Global R&D

Recruiting

Effect of Glycerol-Electrolyte Beverages on Fluid Balance in Healthy Euhydrated Men and Women at Rest

Hydration

United States
SLS France
Global D

Recruiting

To Evaluate the Performance and Safety of Personalized Implants in CMF Surgery Indicated for Orthognathic Surgery

Surgery | Maxilla Fracture

Belgium, France
PepsiCo Global R&D

Completed

A Cross-sectional Online Survey Among Saudi Arabian Population in the Age Group 18-40 Years to Assess Whole Grain (WG) Awareness, Consumption Levels, and Dietary Habits Around Breakfast

Diet, Healthy

Saudi Arabia

3

Subscribe